Validation of the high mortality rate of Malnutrition-Inflammation-Atherosclerosis syndrome
Daisuke Sueta(Mie University), Hisao Ogawa(Jikei University School of Medicine), Tomonori Akasaka, Seiji Hokimoto(Omuta hospital), Koichi Kaikita(Kumamoto University), Noriaki Tabata(Kumamoto University), M Naruse, Osamu Honda, Kenji Sakamoto(Kumamoto University)
Cited by 73
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449